olpruva
Generic: sodium phenylbutyrate
olpruva: developed by 2 companies · 1 FDA decision. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Acer Therapeutics Inc. (ACER) | Approved |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | Approved |
FDA Decisions
Approval(ACER)
Frequently asked questions
Who is developing olpruva?
olpruva is being developed by Acer Therapeutics Inc., ZEVRA THERAPEUTICS, INC..
What is olpruva's latest FDA decision?
The most recent tracked FDA decision for olpruva is Approval, dated December 22, 2022.
Get deeper analysis on olpruva
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis